首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo
【24h】

Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo

机译:BREQUINAR对口蹄疫病毒感染的抗病毒活性在体外和体内

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Foot-and-mouth disease (FMD) is one of the most highly contagious animal disease that affects cloven-hoofed animals. However, the FMD vaccine does not provide effective protection until adaptive immune protection elicited by the vaccination occurs. Therefore, an alternative application of antiviral agents for inhibition of the FMD virus (FMDV) is needed. Here, we demonstrated that brequinar could exhibit antiviral activity in swine kidney cells (IBRS-2 cells) infected with two different FMDV serotypes. Subsequently, in vivo activity of brequinar was confirmed in a mouse model of infection. Specifically, brequinar at a concentration of 50 mu g, provided 25% protection for 5 days following FMDV challenge. These results suggested that brequinar could be used as effective antiviral agent against FMD.
机译:口蹄疫(FMD)是影响偶蹄动物的最具传染性动物疾病之一。 然而,直到发生接种疫苗引起的自适应免疫保护,FMD疫苗没有提供有效的保护。 因此,需要抗病毒剂抑制FMD病毒(FMDV)的替代施用。 在这里,我们证明BREQUINAR可以在感染两种不同的FMDV血清型感染的猪肾细胞(IBRS-2细胞)中表现出抗病毒活性。 随后,在感染的小鼠模型中证实了BREQUINAR的体内活性。 具体地,在FMDV攻击后5天提供50μg的浓度为50μg的BREQUINAR。 这些结果表明,BREQUINAR可以用作针对FMD的有效抗病毒剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号